You are here: Industry Insights > teva

News List

'I'm quite frankly baffled': Teva's $235M overturn in GSK patent case has judge 'bewildered' fiercepharma
September 08, 2019
Facing claims it induced doctors to prescribe a generic version of GlaxoSmithKline’s Coreg that violated its patents, Teva was hit with a hefty $235 million penalty in 2017. But a federal judge overruled that jury’s verdict last year—and now, one federal
Teva Launches Generic Equivalent of EpiPen Jr® americanpharmaceuticalreview
August 22, 2019
Teva Pharmaceutical Industries (NYSE and TASE: TEVA) announced availability of the FDA-approved generic version of EpiPen Jr®1 (epinephrine injection, USP) Auto-Injector, 0.15 mg ...
Lawmakers to Teva, Mylan: Stop stonewalling our price-fixing probe fiercepharma
August 15, 2019
Pharma watchdogs Rep. Elijah Cummings and Sen. Bernie Sanders want answers on generics pricing—and with none forthcoming from the Justice Department, they're pressing drugmakers for the info themselves. Again.
Teva scouts new CFO as McClellan steps down for personal reasons fiercepharma
August 08, 2019
Teva CEO Kåre Schultz has spent nearly two years working through major issues at the generics giant. Now, he’ll need to replace his CFO, as Michael McClellan is stepping down.
Teva settles California’s pay-for-delay allegations pharmaceutical-technology
August 01, 2019
Drug companies Teva Pharmaceutical, Endo Pharmaceuticals and Teikoku Pharma have signed four settlement agreements with the State of California to resolve allegations regarding pay-for-delay deals to prevent cheaper, generic medicines from entering the ma
$70 Million Settlement Reached in Generic Drug Delay Case drugs
July 31, 2019
Three drug companies will pay a total of nearly $70 million to California to settle charges of delaying the sale of generic drugs to keep brand-name drug prices high...
IONTAS, Teva Enter Antibody Optimization Agreement contractpharma
July 30, 2019
Partnership includes options for the screening of biophysical properties suitable for developable antibodies.
Teva claws back $50M from former execs, board members to pay for 2016 foreign bribery settlement fiercepharma
July 28, 2019
Teva was also one of 20 generics makers targeted in 2017 a multistate lawsuit for an alleged price-fixing scheme to prop up the cost of certain generic drugs—sometimes by as much as 1,000%.
Teva Announces FDA approval of AirDuo® Digihaler™ biospectrumasia
July 20, 2019
The First Digital Maintenance Asthma Inhaler Therapy with Integrated Sensors Joins Teva’s Digital Rescue Inhaler Therapy to Provide Patients with Technology to Track Treatment Use
Teva Completes Facilities Purchase in Pennsylvania americanpharmaceuticalreview
July 16, 2019
Teva announced the company has completed the purchase of three buildings on Brandywine Parkway in West Chester, Pa., which, together with three other buildings Teva owns in ...

Previous page 1 2 3 4 5 6 7 8 9 10 ... 14 15 Next page